Nu
Nuevolution (Amgen)
Copenhagen DKFounded 200180 employees
Private CapbiotechAcquiredOncology
Platform: Chemetics
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pexasertib | NUE-7683 | Approved | 2 | MET | ADPKD | ||
| Rilutapinarof | NUE-6133 | Phase 1 | 2 | MET | Parkinson'sObesity |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)